D.E. Shaw & Co’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-374,195
| Closed | -$505K | – | 4724 |
|
2021
Q4 | $505K | Buy |
374,195
+140,855
| +60% | +$190K | ﹤0.01% | 3083 |
|
2021
Q3 | $679K | Sell |
233,340
-106,728
| -31% | -$311K | ﹤0.01% | 2691 |
|
2021
Q2 | $1.19M | Buy |
340,068
+39,236
| +13% | +$137K | ﹤0.01% | 2401 |
|
2021
Q1 | $1.03M | Buy |
300,832
+149,732
| +99% | +$512K | ﹤0.01% | 2165 |
|
2020
Q4 | $2.9M | Buy |
151,100
+48,647
| +47% | +$934K | ﹤0.01% | 1579 |
|
2020
Q3 | $1.38M | Buy |
102,453
+1,378
| +1% | +$18.5K | ﹤0.01% | 1771 |
|
2020
Q2 | $4.28M | Buy |
101,075
+368
| +0.4% | +$15.6K | 0.01% | 1241 |
|
2020
Q1 | $2.78M | Sell |
100,707
-11,290
| -10% | -$312K | ﹤0.01% | 1346 |
|
2019
Q4 | $3.63M | Buy |
111,997
+41,913
| +60% | +$1.36M | ﹤0.01% | 1339 |
|
2019
Q3 | $1.82M | Buy |
+70,084
| New | +$1.82M | ﹤0.01% | 1611 |
|
2018
Q4 | – | Sell |
-18,359
| Closed | -$356K | – | 2806 |
|
2018
Q3 | $356K | Sell |
18,359
-2,423
| -12% | -$47K | ﹤0.01% | 2200 |
|
2018
Q2 | $459K | Sell |
20,782
-15,409
| -43% | -$340K | ﹤0.01% | 2184 |
|
2018
Q1 | $767K | Buy |
+36,191
| New | +$767K | ﹤0.01% | 1921 |
|